Scientific Session

Current Cancer Immunotherapy Landscape and the Future

Speaker(s)

• AP

  Aliyah Pabani, MD, MPH

  Johns Hopkins
  Washington, District of Columbia, United States

  Disclosure(s): Bristol-Myers Squibb(BMS): Grant/Research Support (Ongoing); Partner Therapeutics: Advisory Board (Terminated, April 8, 2025); Regeneron: Consultant (Ongoing), Grant/Research Support (Ongoing)